JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swinyard, E. A.
Right arrow Articles by Goodman, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swinyard, E. A.
Right arrow Articles by Goodman, L. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 105, Issue 3, 365-370, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF LIVER INJURY AND NEPHRECTOMY ON THE ANTICONVULSANT ACTIVITY OF OXAZOLIDINE-2,4-DIONES

Ewart A. Swinyard 1, Donald O. Schiffman 1, and Louis S. Goodman 1

1 Departments of Pharmacology, University of Utah College of Pharmacy and College of Medicine, Salt Lake City, Utah

Trimethadione and paramethadione were tested at various time intervals after their administration in normal, liver-injured and nephrectomized rats for their ability to prevent the tonic extensor component of maximal electroshock seizures. The results were analyzed for the effect of liver injury and nephrectomy on the potency and the duration of anticonvulsant action of these compounds. Liver injury significantly increased the potency and the duration of action of both drugs. On the other hand, bilateral nephrectomy increased the potency and the duration of action only of paramethadione; within the time intervals employed, this procedure had no significant effect on the anticonvulsant properties of trimethadione.

The results suggest that, in the rat, the liver is the principal organ for the degradation of trimethadione into products devoid of anticonvulsant action, and that the kidney plays no important role in the metabolic alteration or excretion of this compound; in contrast, both the liver and the kidney appear to be concerned in the degradation and elimination of paramethadione.

Submitted on March 24, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.